We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLX icon
2451
Sixth Street Specialty
TSLX
$1.82B
$120K ﹤0.01%
5,702
+1,573
+38% +$33.8K
TTD icon
2452
Trade Desk
TTD
$6.84B
$120K ﹤0.01%
1,830
-5,280
-74% -$408K
VIR icon
2453
Vir Biotechnology
VIR
$1.52B
$120K ﹤0.01%
2,339
+961
+70% +$51.8K
WASH icon
2454
Washington Trust Bancorp
WASH
$767M
$120K ﹤0.01%
2,318
+1,336
+136% +$64.8K
DHC
2455
Diversified Healthcare Trust
DHC
$2.03B
$119K ﹤0.01%
24,978
+10,841
+77% +$49.9K
IIIV icon
2456
i3 Verticals
IIIV
$325M
$119K ﹤0.01%
3,824
+3,152
+469% +$100K
LFMD icon
2457
LifeMD
LFMD
$167M
$119K ﹤0.01%
+7,549
New +$136K
TXMD icon
2458
TherapeuticsMD
TXMD
$24.1M
$119K ﹤0.01%
1,775
+1,050
+145% +$82.2K
TVTY
2459
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$119K ﹤0.01%
5,354
+2,791
+109% +$64K
VEDL
2460
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$119K ﹤0.01%
9,452
+7,301
+339% +$79.4K
ABCL icon
2461
AbCellera Biologics
ABCL
$3.36B
$118K ﹤0.01%
3,464
+3,110
+879% +$124K
AVD icon
2462
American Vanguard Corp
AVD
$62.8M
$118K ﹤0.01%
5,771
-3,811
-40% -$72.6K
AXTI icon
2463
AXT Inc
AXTI
$5.07B
$118K ﹤0.01%
10,093
+8,010
+385% +$96.2K
BBAG icon
2464
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$998M
$118K ﹤0.01%
+2,200
New +$120K
EBF icon
2465
Ennis
EBF
$559M
$118K ﹤0.01%
5,532
-11,191
-67% -$222K
FHLC icon
2466
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
$118K ﹤0.01%
1,997
+1,995
+99,750% +$118K
HEES
2467
DELISTED
H&E Equipment Services
HEES
$118K ﹤0.01%
3,126
+1,348
+76% +$43.1K
INN
2468
Summit Hotel Properties
INN
$656M
$118K ﹤0.01%
11,555
+207
+2% +$2K
KURA icon
2469
Kura Oncology
KURA
$896M
$118K ﹤0.01%
4,185
-259
-6% -$8.2K
PTEN icon
2470
Patterson-UTI
PTEN
$4.16B
$118K ﹤0.01%
16,518
+11,010
+200% +$77.6K
RDNT icon
2471
RadNet
RDNT
$6.08B
$118K ﹤0.01%
5,454
+3,275
+150% +$66.2K
SCS
2472
DELISTED
Steelcase
SCS
$118K ﹤0.01%
8,202
-148
-2% -$2.1K
SOXL icon
2473
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$24.8B
$118K ﹤0.01%
3,081
-198,549
-98% -$7.43M
VERU icon
2474
Veru
VERU
$46M
$118K ﹤0.01%
1,100
+350
+47% +$44.1K
CUTR
2475
DELISTED
Cutera, Inc.
CUTR
$118K ﹤0.01%
3,954
-2,743
-41% -$81.1K

Similar funds

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.